- Home
- HPI vs ORIC Comparison
HPI vs ORIC Comparison
Compare HPI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPI
- ORIC
- Stock Information
- Founded
- HPI 2002
- ORIC 2014
- Country
- HPI United States
- ORIC United States
- Employees
- HPI N/A
- ORIC N/A
- Industry
- HPI Trusts Except Educational Religious and Charitable
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- HPI Finance
- ORIC Health Care
- Exchange
- HPI Nasdaq
- ORIC Nasdaq
- Market Cap
- HPI 431.9M
- ORIC 362.9M
- IPO Year
- HPI N/A
- ORIC 2020
- Fundamental
- Price
- HPI $16.10
- ORIC $5.08
- Analyst Decision
- HPI
- ORIC Strong Buy
- Analyst Count
- HPI 0
- ORIC 8
- Target Price
- HPI N/A
- ORIC $18.83
- AVG Volume (30 Days)
- HPI 64.7K
- ORIC 630.2K
- Earning Date
- HPI 01-01-0001
- ORIC 05-05-2025
- Dividend Yield
- HPI 8.97%
- ORIC N/A
- EPS Growth
- HPI N/A
- ORIC N/A
- EPS
- HPI N/A
- ORIC N/A
- Revenue
- HPI N/A
- ORIC N/A
- Revenue This Year
- HPI N/A
- ORIC N/A
- Revenue Next Year
- HPI N/A
- ORIC N/A
- P/E Ratio
- HPI N/A
- ORIC N/A
- Revenue Growth
- HPI N/A
- ORIC N/A
- 52 Week Low
- HPI $12.85
- ORIC $3.90
- 52 Week High
- HPI $16.83
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- HPI 55.88
- ORIC 44.71
- Support Level
- HPI $15.71
- ORIC $4.52
- Resistance Level
- HPI $15.99
- ORIC $5.83
- Average True Range (ATR)
- HPI 0.19
- ORIC 0.52
- MACD
- HPI 0.10
- ORIC 0.07
- Stochastic Oscillator
- HPI 86.10
- ORIC 40.58
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.